Similarly, PSMD3 was shown to be overexpressed at the protein level in human epidermal growth factor receptor 2 (HER2)-positive breast cancer, helping to stabilize HER2 and culminating in a worse overall survival (OS). Here, ERBB2 is linked to breast carcinoma.